Patrick Grierson, M.D., Ph.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick Grierson, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:21 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07126158 · Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic AdenocarcinomaWashington University School of Medicine · recruiting · Pancreatic Adenocarcinoma, Cancer of the Pancreas, Pancreas Cancer · principal investigator
- Ph2NCT07101666 · Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric CancerWashington University School of Medicine · not yet recruiting · Gastric Cancer · principal investigator
- Ph1/Ph2NCT06904378 · ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal AdenocarcinomaWashington University School of Medicine · recruiting · Metastatic Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph1NCT05187182 · CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal CancerWashington University School of Medicine · recruiting · Gastric Cancer, Esophageal Cancer, Stomach Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDACP50CA272213 · NCI · WASHINGTON UNIVERSITY · PI WILLIAM G HAWKINS · fiscal years 2023 to 2026Named on NCT06904378
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.